Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Ultragenyx Pharmaceuticals won approval for its newest gene therapy on Thursday, helping shares partially reverse a catastrophic dive. The post How This Gene Therapy Name Partially Reversed Its Catastrophic 44% Dive appeared first on Investor’s Business Daily.
Crispr stock, alongside other gene-editing equities, pulled a bullish move Thursday — bounding for a breakout from a cup-with-handle base. The post Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout appeared first on Investor’s Business Daily.
The Philadelphia semiconductor index, known as SOX, rose for the third straight session Thursday. AMD stock was among the big gainers. The post AMD Leads Chip Stocks Higher Amid Sector Rebound appeared first on Investor’s Business Daily.
U.S. wireless carrier promotions should provide a boost for Apple iPhone 18 Pro sales, a Wall Street analyst says. Apple stock rose slightly. The post Apple iPhone 18 Pro Sales Helped By Carrier Promotions appeared first on Investor’s Business Daily.
A September rally set up its Connect developer conference as a test of investor confidence. The post Meta Stock Climbs On Muse AI Excitement. Here’s The Next Potential Catalyst. appeared first on Investor’s Business Daily.
Ciena stock climbed after the optical gear maker announced new financial targets, including 30% sales growth, at an investor briefing. The post Ciena Stock Climbs On Three-Year, 30% Revenue Growth Outlook appeared first on Investor’s Business Daily.
Nebius stock popped after the cloud computing specialist announced price hikes of around 20% effective Oct. 1. The post Nebius Stock Jumps On Cloud Computing Price Hikes appeared first on Investor’s Business Daily.
Salesforce stock dipped ahead of an investor briefing after the market close and reports of a global system outage. The post Salesforce Stock Dips Ahead Of Investor Briefing Amid System Outage appeared first on Investor’s Business Daily.
TG Therapeutics stock showed technical strength Wednesday, bounding off its 50-day moving average and nearing a breakout on the weekly chart. The post TG Therapeutics Makes A Bullish Move Amid Ongoing Roche Rivalry appeared first on Investor’s Business Daily.
Novartis added another failure to its docket Wednesday, dropping an experimental treatment for the muscle-wasting disease. The post Novartis Suffers Another Setback After Two High-Profile Surprises Hammered Shares appeared first on Investor’s Business Daily.
